CRH (CRH) H2 2015 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2015 earnings summary
19 Nov, 2026Executive summary
FY15 delivered strong profit growth from acquired assets and heritage operations; organic EBITDA rose 13% on 3% organic sales growth, with 40% operating leverage.
Returns and margins improved for a second consecutive year, while year-end net debt fell below 3x EBITDA.
Financial highlights
Revenue was €23.6bn, up 25% YoY; EBITDA was €2.2bn, up 35%.
Organic EBITDA contribution increased €258m; currency added €218m and development activity net of disposals added €115m.
Operating cash flow was €1.3bn; working capital generated a €642m inflow, and capex rose significantly YoY.
LafargeHolcim-related one-off transaction costs were just under €200m; excluding these largely non-tax-deductible costs, the effective tax rate was ~25.8%.
Outlook and guidance
FY16 expected to deliver continued growth; European markets seen slightly better overall, while mixed, and early-year activity was solid across main markets.
U.S. FY16 outlook: infrastructure activity may rise 2%-3%, residential growth 3%-5%, and non-residential growth 3%-4%; visibility extends to midyear.
FY16 capex guided at ~100%-105% of depreciation, or over €1bn; development spend expected to remain ~30% of total.
European cement pricing remains challenging and mixed; modest increases expected in some eastern markets, the U.K. and Netherlands.
Energy costs excluding bitumen expected flat to slightly higher in FY16; Americas Materials expected to expand margins from FY15 levels.
Latest events from CRH
- Strong growth and cash generation cut leverage to 1.7x while supporting further growth.CRH
H2 2016 - €3.3bn EBITDA, stronger margins and returns, and major acquisitions positioned for further growth.CRH
H2 2017 - U.S. momentum and cost actions supported 2013 progress as net debt fell EUR 519m.CRH
H2 2012 - H2 momentum improved as portfolio actions and disciplined investment set up a moderate 2014 recovery.CRH
H2 2013 - EBITDA rose 11% in 2014; 2015 priorities were growth, integration and debt reduction.CRH
H2 2014 - Sales rose 5% and EBITDA reached €1.66bn as margins proved resilient.CRH
H2 2011 - Cash discipline and cost savings steadied results as markets began to stabilize.CRH
H2 2010 - Q3 EBITDA held near prior year; FY26 guidance is $7.8B–$8.0B amid cost and residential headwinds.CRH
Q3 2026 - Q2 2026 saw strong growth, margin gains, and the Arcosa deal, supporting a positive outlook.CRH
Q2 2026